Chang Jiang Scholar's Laboratory/Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou University Medical College, Shantou, Guangdong Province, People's Republic of China.
The Breast Center, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong Province, 515031, People's Republic of China.
Mol Imaging Biol. 2018 Oct;20(5):761-770. doi: 10.1007/s11307-018-1180-4.
Dysregulation of microRNAs (miRNAs) are not only involved in the formation of malignant tumors but also in the processes of differentiation and aggressiveness. However, current methods for detecting miRNA expression have major disadvantages, such as being invasive and non-reproducible. The epithelial-mesenchymal transition (EMT) has been implicated as a pivotal event in the metastasis, stemness, and chemoresistance of malignant tumors.
In our study, we constructed a new reporter gene, Luc2/tdT_miR200c_3TS, to examine the in vitro and in vivo expression of miR-200c, an EMT-associated miRNA. Quantitative real-time PCR was used to measure the expression levels of miR-200c and EMT-related mRNA, and luciferase assay and bioluminescence imaging were used to measure the luciferase activities in vitro and in vivo, respectively.
We found that the expression level of miR-200c was negatively associated with cell migration and invasion. Luciferase activities were regulated by the differential expression levels of miR-200c and EMT process.
Our results demonstrate that Luc2/tdT_miR200c_3TS may be a useful tool for monitoring the expression level of miR-200c at both the cellular level and in living animals, thereby providing a potential high-throughput approach for anticancer drug screening.
microRNAs(miRNAs)的失调不仅参与了恶性肿瘤的形成,还参与了分化和侵袭性的过程。然而,目前检测 miRNA 表达的方法存在主要缺点,例如具有侵袭性和不可重复性。上皮-间充质转化(EMT)已被认为是恶性肿瘤转移、干性和化疗耐药的关键事件。
在我们的研究中,我们构建了一个新的报告基因 Luc2/tdT_miR200c_3TS,以检测 EMT 相关 miRNA miR-200c 的体外和体内表达。定量实时 PCR 用于测量 miR-200c 和 EMT 相关 mRNA 的表达水平,而荧光素酶测定和生物发光成像分别用于测量体外和体内的荧光素酶活性。
我们发现 miR-200c 的表达水平与细胞迁移和侵袭呈负相关。荧光素酶活性受到 miR-200c 的差异表达水平和 EMT 过程的调节。
我们的结果表明,Luc2/tdT_miR200c_3TS 可能是一种监测 miR-200c 在细胞水平和活体动物中表达水平的有用工具,从而为抗癌药物筛选提供了一种潜在的高通量方法。